306 related articles for article (PubMed ID: 30429477)
1. Whole genome sequencing puts forward hypotheses on metastasis evolution and therapy in colorectal cancer.
Ishaque N; Abba ML; Hauser C; Patil N; Paramasivam N; Huebschmann D; Leupold JH; Balasubramanian GP; Kleinheinz K; Toprak UH; Hutter B; Benner A; Shavinskaya A; Zhou C; Gu Z; Kerssemakers J; Marx A; Moniuszko M; Kozlowski M; Reszec J; Niklinski J; Eils J; Schlesner M; Eils R; Brors B; Allgayer H
Nat Commun; 2018 Nov; 9(1):4782. PubMed ID: 30429477
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of liquid biopsies for detection of emerging mutated genes in metastatic colorectal cancer.
Furuki H; Yamada T; Takahashi G; Iwai T; Koizumi M; Shinji S; Yokoyama Y; Takeda K; Taniai N; Uchida E
Eur J Surg Oncol; 2018 Jul; 44(7):975-982. PubMed ID: 29452859
[TBL] [Abstract][Full Text] [Related]
3. ARHGEF7 promotes metastasis of colorectal adenocarcinoma by regulating the motility of cancer cells.
Lei X; Deng L; Liu D; Liao S; Dai H; Li J; Rong J; Wang Z; Huang G; Tang C; Xu C; Xiao B; Li T
Int J Oncol; 2018 Nov; 53(5):1980-1996. PubMed ID: 30132516
[TBL] [Abstract][Full Text] [Related]
4. Genomic profiles of colorectal carcinoma with liver metastases and newly identified fusion genes.
Oga T; Yamashita Y; Soda M; Kojima S; Ueno T; Kawazu M; Suzuki N; Nagano H; Hazama S; Izumiya M; Koike K; Mano H
Cancer Sci; 2019 Sep; 110(9):2973-2981. PubMed ID: 31293054
[TBL] [Abstract][Full Text] [Related]
5. Primary colorectal cancers and their subsequent hepatic metastases are genetically different: implications for selection of patients for targeted treatment.
Vermaat JS; Nijman IJ; Koudijs MJ; Gerritse FL; Scherer SJ; Mokry M; Roessingh WM; Lansu N; de Bruijn E; van Hillegersberg R; van Diest PJ; Cuppen E; Voest EE
Clin Cancer Res; 2012 Feb; 18(3):688-99. PubMed ID: 22173549
[TBL] [Abstract][Full Text] [Related]
6. Patterns of somatic alterations between matched primary and metastatic colorectal tumors characterized by whole-genome sequencing.
Xie T; Cho YB; Wang K; Huang D; Hong HK; Choi YL; Ko YH; Nam DH; Jin J; Yang H; Fernandez J; Deng S; Rejto PA; Lee WY; Mao M
Genomics; 2014 Oct; 104(4):234-41. PubMed ID: 25066378
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of proprotein convertases represses the metastatic potential of human colorectal tumor cells.
Scamuffa N; Siegfried G; Bontemps Y; Ma L; Basak A; Cherel G; Calvo F; Seidah NG; Khatib AM
J Clin Invest; 2008 Jan; 118(1):352-63. PubMed ID: 18064302
[TBL] [Abstract][Full Text] [Related]
8. KRAS and 2 rare PI3KCA mutations coexisting in a metastatic colorectal cancer patient with aggressive and resistant disease.
Tessitore A; Bruera G; Mastroiaco V; Cannita K; Cortellini A; Cocciolone V; Dal Mas A; Calvisi G; Zazzeroni F; Ficorella C; Ricevuto E; Alesse E
Hum Pathol; 2018 Apr; 74():178-182. PubMed ID: 29409955
[TBL] [Abstract][Full Text] [Related]
9. PI3K/Akt/mTOR Signaling and Plasma Membrane Proteins Are Implicated in Responsiveness to Adjuvant Dendritic Cell Vaccination for Metastatic Colorectal Cancer.
Qian DC; Xiao X; Byun J; Suriawinata AA; Her SC; Amos CI; Barth RJ
Clin Cancer Res; 2017 Jan; 23(2):399-406. PubMed ID: 27435399
[TBL] [Abstract][Full Text] [Related]
10. H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b.
Vennin C; Spruyt N; Dahmani F; Julien S; Bertucci F; Finetti P; Chassat T; Bourette RP; Le Bourhis X; Adriaenssens E
Oncotarget; 2015 Oct; 6(30):29209-23. PubMed ID: 26353930
[TBL] [Abstract][Full Text] [Related]
11. Site-specific gene expression profiles and novel molecular prognostic factors in patients with lower gastrointestinal adenocarcinoma diffusely metastatic to liver or peritoneum.
Varghese S; Burness M; Xu H; Beresnev T; Pingpank J; Alexander HR
Ann Surg Oncol; 2007 Dec; 14(12):3460-71. PubMed ID: 17899288
[TBL] [Abstract][Full Text] [Related]
12. MACC1 mRNA levels predict cancer recurrence after resection of colorectal cancer liver metastases.
Isella C; Mellano A; Galimi F; Petti C; Capussotti L; De Simone M; Bertotti A; Medico E; Muratore A
Ann Surg; 2013 Jun; 257(6):1089-95. PubMed ID: 23665971
[TBL] [Abstract][Full Text] [Related]
13. Establishment and characterization of 12 human colorectal-carcinoma cell lines.
Oh JH; Ku JL; Yoon KA; Kwon HJ; Kim WH; Park HS; Yeo KS; Song SY; Chung JK; Park JG
Int J Cancer; 1999 Jun; 81(6):902-10. PubMed ID: 10362137
[TBL] [Abstract][Full Text] [Related]
14. An unconventional KITENIN/ErbB4-mediated downstream signal of EGF upregulates c-Jun and the invasiveness of colorectal cancer cells.
Bae JA; Yoon S; Park SY; Lee JH; Hwang JE; Kim H; Seo YW; Cha YJ; Hong SP; Kim H; Chung IJ; Kim KK
Clin Cancer Res; 2014 Aug; 20(15):4115-28. PubMed ID: 24893630
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of primary tumour and matched metastases in colorectal cancer patients: evaluation of concordance between genomic and transcriptional profiles.
Vignot S; Lefebvre C; Frampton GM; Meurice G; Yelensky R; Palmer G; Capron F; Lazar V; Hannoun L; Miller VA; André F; Stephens PJ; Soria JC; Spano JP
Eur J Cancer; 2015 May; 51(7):791-9. PubMed ID: 25797355
[TBL] [Abstract][Full Text] [Related]
16. KRAS and BRAF mutation status in circulating colorectal tumor cells and their correlation with primary and metastatic tumor tissue.
Mostert B; Jiang Y; Sieuwerts AM; Wang H; Bolt-de Vries J; Biermann K; Kraan J; Lalmahomed Z; van Galen A; de Weerd V; van der Spoel P; RamÃrez-Moreno R; Verhoef C; Ijzermans JN; Wang Y; Gratama JW; Foekens JA; Sleijfer S; Martens JW
Int J Cancer; 2013 Jul; 133(1):130-41. PubMed ID: 23233388
[TBL] [Abstract][Full Text] [Related]
17. Enrichment of PI3K-AKT-mTOR Pathway Activation in Hepatic Metastases from Breast Cancer.
Pierobon M; Ramos C; Wong S; Hodge KA; Aldrich J; Byron S; Anthony SP; Robert NJ; Northfelt DW; Jahanzeb M; Vocila L; Wulfkuhle J; Gambara G; Gallagher RI; Dunetz B; Hoke N; Dong T; Craig DW; Cristofanilli M; Leyland-Jones B; Liotta LA; O'Shaughnessy JA; Carpten JD; Petricoin EF
Clin Cancer Res; 2017 Aug; 23(16):4919-4928. PubMed ID: 28446508
[No Abstract] [Full Text] [Related]
18. MicroRNA-137, an HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2.
Liang L; Li X; Zhang X; Lv Z; He G; Zhao W; Ren X; Li Y; Bian X; Liao W; Liu W; Yang G; Ding Y
Gastroenterology; 2013 Mar; 144(3):624-635.e4. PubMed ID: 23201162
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide mutation profiles of colorectal tumors and associated liver metastases at the exome and transcriptome levels.
Lim B; Mun J; Kim JH; Kim CW; Roh SA; Cho DH; Kim YS; Kim SY; Kim JC
Oncotarget; 2015 Sep; 6(26):22179-90. PubMed ID: 26109429
[TBL] [Abstract][Full Text] [Related]
20. c-Kit is suppressed in human colon cancer tissue and contributes to L1-mediated metastasis.
Gavert N; Shvab A; Sheffer M; Ben-Shmuel A; Haase G; Bakos E; Domany E; Ben-Ze'ev A
Cancer Res; 2013 Sep; 73(18):5754-63. PubMed ID: 24008320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
